Bret Heileson
Family Medicine · Bethany, MONPI 1912982075
Payments from drug & device makers
Across 216 payments — averaging $15.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$494
- Lilly USA, LLC$283
- Amgen$268
- Novartis$261
- AstraZeneca$260
- Bayer$228
- plus $2K from 30 others
What the payments were for
- Food & beverage$3,412100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 32 | $494 |
| Lilly USA, LLC | 16 | $283 |
| Amgen | 19 | $268 |
| Novartis | 15 | $261 |
| AstraZeneca(2 entities) | 17 | $260 |
| Bayer | 13 | $228 |
| Pfizer | 18 | $227 |
| AbbVie | 7 | $142 |
| Johnson & Johnson | 10 | $139 |
| Boehringer Ingelheim | 8 | $132 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $119 |
| Merck | 7 | $91 |
| E.r. Squibb & Sons, L.L.C. | 7 | $87 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $79 |
| Genentech USA, Inc. | 3 | $53 |
| VBI Vaccine (delaware) Inc. | 2 | $43 |
| GSK | 3 | $41 |
| Amarin Pharma, Inc. | 2 | $41 |
| Agile Therapeutics, Inc. | 2 | $38 |
| Eisai Inc. | 2 | $37 |
| Bioxcel Therapeutics, Inc. | 2 | $37 |
| Mylan Specialty L.p. | 2 | $34 |
| Currax Pharmaceuticals LLC | 2 | $33 |
| Ultragenyx Pharmaceutical Inc. | 2 | $28 |
| Astellas Pharma US Inc | 2 | $25 |
| Alkermes, Inc. | 1 | $25 |
| Biohaven Pharmaceuticals, Inc. | 1 | $24 |
| Abbott | 1 | $24 |
| Medtronic | 1 | $21 |
| Biogen | 1 | $16 |
| Dexcom, Inc. | 1 | $15 |
| Lundbeck LLC | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
| Vertex | 1 | $14 |
| Amneal Pharmaceuticals LLC | 1 | $13 |
| Jazz Pharmaceuticals Inc. | 1 | $13 |
How this compares
$3,412 in reported general payments places this provider in the 80th percentile of 2,203 family medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 57 | $34,776 |
| XareltoRivaroxaban | 38 | $33,398 |
| TrulicityDulaglutide | 18 | $27,051 |
| Tresiba Flextouch U-200Insulin Degludec | 27 | $25,308 |
| RybelsusSemaglutide | 15 | $20,069 |
| FarxigaDapagliflozin Propanediol | 21 | $18,602 |
| SynjardyEmpagliflozin/Metformin Hcl | 18 | $16,802 |
| JardianceEmpagliflozin | 22 | $11,241 |
| Breo ElliptaFluticasone/Vilanterol | 19 | $9,575 |
| LinzessLinaclotide | 18 | $9,197 |
| MyrbetriqMirabegron | 17 | $7,498 |
| Bydureon BciseExenatide Microspheres | 11 | $7,302 |
| JanuviaSitagliptin Phosphate | 13 | $6,539 |
| Divalproex Sodium ErDivalproex Sodium | 23 | $2,104 |
| Gabapentin | 88 | $1,626 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $227 | $34,77657 claims |
| Johnson & JohnsonXarelto | $139 | $33,39838 claims |
| Boehringer IngelheimSynjardy, Jardiance | $132 | $28,04340 claims |
| Lilly USA, LLCTrulicity | $283 | $27,05118 claims |
| Novo NordiskRybelsus | $494 | $20,06915 claims |
| AstraZenecaFarxiga | $260 | $18,60221 claims |
| GSKBreo Ellipta | $41 | $9,57519 claims |
| AbbVieLinzess | $142 | $9,19718 claims |
| Astellas Pharma US IncMyrbetriq | $25 | $7,49817 claims |
| MerckJanuvia | $91 | $6,53913 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $13 | $1,257182 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Bethany
- Timothy JenningsMaryland Heights$30.2M
- William HowittSpringfield$19.9M
- Rupal TrivediSaint Louis$10.6M
- Frederic PraterMaryland Heights$9.1M
- Leea ReedRogersville$7.9M
- Dennis MorrisonSpringfield$5.7M
- Luke van KirkSpringfield$5.6M
- Amy RobertsTown And Country$4M
- Scott KuennenKansas City$2.2M
- George CarrJefferson City$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.